Introduction. ADAM33 is the candidate gene most commonly associated with asthma and airway hyperreactivity (AHR). Aim. The aim of this study was to determine whether level of AHR is associated with certain alleles or haplotypes of the ADAM33 gene in asthmatic children. Methods. One hundred and nine asthmatic children and 46 controls from the general population were examined with spirometry before and after histamine and methacholine inhalation. All subjects were genotyped for single-nucleotide polymorphisms (SNPs) of the ADAM33 gene. Haplotypes were determined according to genotypes of the patient's parents. Results. We found the three most frequent ADAM33 haplotypes (a1-3) were associated with the highest level of AHR to methacholine and histamine in 66% of asthmatic children. The paternally transmitted GGGCTTTCGCA haplotype was seen in 73.3% asthmatic children with serious AHR to methacholine challenge (paternal and maternal origin of haplotype 73.3% to 37.5, P=0.046) Significant differences in the relative frequency of paternal haplotypes with high levels of AHR to histamine were found (P=0.013). Conclusion. ADAM33 haplotypes (a1, a2, a3) are associated with severity of AHR and are significantly more often transmitted in the paternal line.
INTRODUCTION
Asthma is heterogeneous disorder of the airways, with intermittent airflow obstruction frequently accompanied by increased responsiveness of the bronchi to a wide variety of exogenous and endogenous stimuli. The main pathogenic mechanism of asthma is thought to be of chronic eosinophil-based inflammation of the bronchial mucosa. Airway hyperresponsiveness (AHR) is one of the key features of asthma and is known to directly correlate with the severity of asthmatic symptoms 1 . Complex interactions between environmental and genetic factors give rise to the clinical appearance of asthma. In the last decade, candidate genes responsible for asthma development have been identified. ADAM33 (a disintegrin and metallopeptidase domain 33) is one of genes identified in a locus on the short arm of chromosome 20 that has been linked to asthma and bronchial hyperresponsiveness (Ref Shapiro NEJM 2002) 2 . ADAM33 belongs to a subgroup of metalloproteinases and is expressed by lung fibroblasts and bronchial smooth-muscle cells 1 . Several polymorphisms of ADAM33 gene have been studied. Several single-nucleotide polymorphisms (SNPs) are associated with asthma in some studies but others are not linked to the disease [3] [4] [5] [6] . Since each of the SNPs probably contributes to the overall manifestation of asthma, haplotype association studies may be more revealing (ref Ederwegh and Howard) . Distinct asthma susceptibility genomic loci have also been mapped to chromosomal region 12q13-24. This region is linked to bronchial asthma and to associated phenotypes, such as elevated IgE levels [7] [8] [9] . AHR is usually defined as increased sensitivity of the airways to a variety of nonsensitizing agents that act via different specific mechanisms 3, 4 . It may reflect a common physiological pathway of several mechanisms leading to a lowered threshold of airway narrowing to bronchoconstrictive stimuli. Measurement of bronchial hyperreactivity provides quantitative insights into variable airflow obstruction. Histamine and methacholine act directly on the airway smooth muscle. Methacholine is an acetylcholine analogue that lacks the nicotinic action of acetylcholine. The sensitivity of the airways to these agents is commonly expressed as a provocative concentration/dose causing a 20% fall (PC/D20) in forced expiratory volume in 1 s (FEV1). When exposed to high concentrations of inhaled histamine or methacholine, asthmatic patients show excessive narrowing of the airway, as reflected by an elevated or absent maximal response plateau [10] [11] [12] . Environmental influences and epigenetic mechanisms could pose important modifying factors shaping the asthma phenotype at the clinical level. General mechanisms of gene expression regulation are methylation and histone acetylation. Increase in histone acetyltransferase activity with decrease in histone deacetylase have been observed in asthma 13 . The aim of this study was to find whether ADAM33 SNPs are associated with asthma and the results of histamine and methacholine bronchoprovocation tests as assessed by dosimetry. We performed genotyping of some previously reported polymorphisms and examined the possible association of these polymorphisms and their haplotypes with asthma in families with asthmatic children.
PATIENTS AND METHODS
Our study was performed on a population of 109 children with asthma and their relatives (parents and siblings). Overall 375 persons in 108 families and 46 samples from the general population were studied.
The diagnosis of persistent mild atopic bronchial asthma (a positive skin prick test) was established, using the In all patients, the existence of atopy was evaluated by a skin prick test using common allergen extracts (grass and tree pollen, house dust mite, molds, cat dog extracts) and reactions 3 mm were regarded as positive (fy Stallergen).
Spirometry was performed in children prior to initiation of anti-inflammatory therapy. All subjects used antihistamines for a week prior to the testing. Salbutamol was not allowed in the morning before assessment. At the time of the study, all subjects had been free of any acute respiratory tract infection for 4 weeks. Subjects with baseline FEV1<80% of the predicted value were excluded.
Children with congenital airway anomalies or severe respiratory tract disease (e.g., cystic fibrosis) were excluded from the study. The study was approved by the Hospital Ethics Committee, and the parents of all children gave informed consent.
Spirometry
We used the Jaeger MasterScreen Spirometry system (Jaeger Co., Germany). Pulmonary function tests were performed in the sitting position. Baseline value at screening of FEV1, obtained from analysis of three consecutive efforts, was ≥80% of predicted, with <5% variability. Each data point was the best of at lest three reproducible measurements (variability <5%). The result of pulmonary function test indices were expressed as absolute values and percentage of predicted values. The predicted values for each subject based on gender, age, weight and height were obtained from standard computerized formulas (ECCS 1993, Zapletal 1987 for children) (ref.
14 ). The histamine and methacholine solutions were prepared in different concentrations in buffered saline (pH 7.4) ( Tables 1, 2 ). Each patient inhaled prepared histamine or methacholine solutions in increasing concentrations. The test was stopped when the fall in FEV1 was ≥20% compared to baseline.
Genotyping and haplotyping
DNA isolation from samples of whole peripheral blood was performed by standard salting out method. Genotypes in patients, their relatives and controls were identified using the allele discrimination/SNP's real time PCR. The probes for discrimination/SNP's real time PCR were obtained from the Applied Biosystem database of TaqMan® SNP genotyping assays or were alternatively designed by the manufacturer according to ours specifications. The PCR reaction was carried out in overall volume of 11 µL with these components: 6.28 µL H 2 O, 0.02 µL reference dye Rox 50x (Finnzymes), 4.0 µL DyNamo™ Haplotypes were determined according to genotypes of the patient's parents. Nonconclusive haplotypes were inferred by using expectation maximization algorithm modified by partition ligation mode 41 and also using Bayes'theorem42.
Statistics
Standard non-parametric statistics were used to describe primary data, i.e. absolute and relative frequencies, median and 10 th -90 th percentile range. Decrease in FEV≥20% following histamine and methacholine inhalations were binary coded and analyzed statistically as a categorical variable. ML-χ 2 test. Fisher's exact test was applied to assess associations among variants in categorical variables. When needed, standard Bonferroni correction was used for multiple comparisons. Corrections were done separately for SNPs and for haplotypes [15] [16] [17] [18] .
RESULTS
109 children (76 boys and 33 girls) were included in the study, they were all assessed between 2003 and 2005 and given a diagnosis of moderate, persistent bronchial asthma according to GINA 2002. Genotypes (and allele frequencies) for the studied ADAM33 SNPs were successfully determined in all of the patients (109 asthmatic), relatives (parents and siblings) and 46 controls from the general population. We found some differences in allele frequencies of the studied SNPs between patients and control groups but these did not reach statistical significance (Table 3) .
Based on the knowledge of parental genotypes in ADAM33 SNPs, we constructed haplotypes in patients (built from rs511898, rs2280092, rs3918396, rs528557, rs2853209, rs44707, rs2280091, rs2280089, rs628977, rs2787094, rs3746631 SNPs, respectively) ( Table 4 ). The haplotypes were successfully determined in 64% for ADAM33 in patients and in 23.9% in the control group. We found three haplotypes were most common and we denoted them as a1-a3 for ADAM33 in descending order Table 3 . Frequencies of ADAM33 SNPs. The first one nucleotide each of SNP represents major allele, and then homozygote 1 is homozygote for major allele. F+1 (rs511898), L-1 (rs2280092), S1 (rs3918396), S2 (rs528557), S+1 (rs2853209), ST+4 (rs44707), T1 (rs2280091), T+1 (rs2280089), V_3 (rs628977), V4 (rs2787094), V5 (rs3746631), according to frequency. The frequency of the most common ADAM33 haplotypes was not significantly different for patients and controls (Table 5) . We were unable to analyze minor haplotypes but their mild contribution (together as a group) to the final asthma phenotype cannot be ruled out. One hundred and nine children started the histamine bronchoprovocation tests. All histamine and methacholine bronchoprovocation tests were completed by 99 children with a percentage decrease in FEV1≥20% to baseline FEV1. Cough and nausea developed as the percentage of FEV1≥20% decreased in 53 (75%) children using histamine and in 41 (58%) children using methacholine. Low level of AHR PC -2 mg/mL histamine (Provocation concentration) and -16 mg/mL methacholine was observed in 28 (28%) of the asthmatic children (group I). Medium to high level of AHR PC 20 ≤ 2mg/mL histamine and PC20 ≤16 mg/mL methacholine was observed in 71 (72%) of the asthmatic children (group II).
SNP/ Genotypes
We investigated the association of ADAM33 haplotypes to level of AHR in histamine and methacholine bronchoprovocation tests in asthmatic patients. All three most common haplotypes (a1-3) were related to AHR in 47 asthmatic children (66%).
Medium-high levels of AHR were linked significantly to a3 haplotype and moreover there was a difference in a3 haplotype distribution according to parental origin -73.3% of patients with positive bronchoprovation test after methacholine challenge shared a3 haplotype of paternal origin (P=0.046) vs. 37.5% of patients with maternal origin of the haplotype. We found statistically significant differences in relative frequency of paternal haplotypes with serious levels of AHR to histamine (P=0.013) (Tables  6 a,b) .
The other ADAM33 haplotypes were also associated with AHR, although their linkage was not as significant as for a3, and hence the effect on AHR by themselves could not be distinguished.
DISCUSSION
In this study, we investigated the influence of 11 ADAM33 SNPs on asthma and the level of AHR in intron or untranslated regions (UTR) regions. We investigated ADAM33 SNPs in 109 children with asthma and 46 healthy controls. We found differences in SNPs distribution between asthmatics and controls but they were not significant. The group size was relatively small but sufficient for statistical significance, as seen in similar studies. ADAM33 was identified as an asthma susceptibility gene using a positional cloning approach in sib-pair populations from the United States and the United Kingdom. In four independent asthma populations (African American, US Caucasian, US Hispanic, and Dutch Caucasian) linkage to chromosome 6p was found only in the US Caucasian population. The lack of linkage in the other populations suggests that ADAM33 confers a modest effect but a fairly large attributable risk, as previously described for complex disease genes in which common alleles contribute to susceptibility 4 . We compared allele and common haplotype (constructed from SNPs found in all relevant studies) from our study with published data from Caucasian populations 19, 20 and we found that the frequencies of SNPs were similar.
The studies used a software-based procedure (an expectation-maximisation algorithm) for haplotype structure identification and to determine whether the differences in Table 6 . Association a1 -a3 ADAM33 paternal and maternal haplotypes to histamine and methacholine bronchoprovocation tests , a2, a3 -haplotypes, group II. -medium -serious level of AHR -PC 20 ≤2 mg/ml histamine and PC20 ≤16 mg/ml methacholine was performed in 47 (66%) asthmatic children, analysis of N = 71 patients 1 P value of ML-χ 2 test a-b Marks of statistical significance -haplotypes marked by different letters are mutually significantly different in relative frequency of II. group haplotype frequencies were due to the haplotype structure themselves. Three most common haplotypes showed a correlation with the severity of AHR (Tables 7, 8) .
Airway hyperresponsiveness is a characteristic feature of asthma. Since its first description in 1946, the measurement of airway responsiveness with inhaled bronchoconstrictor stimuli, such as methacholine or histamine, has become a routine practice in the diagnosis and follow-up of asthma patients. The association between AHR and bronchial inflammation in asthma is supported by the observation that AHR increases with allergen exposure and is reduced by allergen avoidance and anti-inflammatory treatment. Histamine and methacholine act directly on the airway smooth muscle, while AMP-induced bronchoconstriction occurs predominantly indirectly by stimulation of adenosine A2B receptors on mast cells that facilitate their release of inflammatory mediators. Assessment of AHR provides information on the severity of the disease or effect of treatment used (at an interval) and, indirectly, on patient compliance 21, 22 .
We tested whether 11 of the SNPs for ADAM33 could be associated with asthma or AHR in our patient sample. We compared the allele frequencies and frequencies of the most common haplotypes from our study with published data on Caucasian populations and found that the SNP frequencies were similar (data not shown). Some of the ADAM33 haplotypes had greater frequency differences to our study and two others (Tables 7 and 8 ) (ref. 19, 20 ). The haplotype analysis showed no association with asthma.
We found an association of severity of AHR predominantly with the a3 haplotype and differences in a3 haplotype distribution according to parental origin. The differences in frequencies in studies of all three haplotypes but mainly in the case of the a3 haplotype, could be explained by the different way of haplotype construction rather than differences in the haplotype distribution between studies.
The correlation of haplotypes with AHR severity may reflect the role of ADAM33 in intercellular adhesion because of its disintegrin domain support α9β1 - integrin dependent leucocyte adhesion and the fact that mesenchymal cells, such as fibroblasts and smooth muscle cells, express this integrin 23, 24 . The combinations of SNP genotypes in haplotypes could influence disintegrin domain function in intercellular adhesion, and therefore, influence the quantity of leukocytes and inflammatory reaction itself in airways. ADAM33 is a key molecule in the development and progression of asthma by influencing smooth muscle, vascular modeling and remodeling and, severity of AHR. Significant associations were found between the severity of AHR and phenotypes of asthmatics in our study.
CONCLUSIONS
The parental origin of asthma has been known for a long time. Reduced risk of asthma and AHR in children has been associated with the Val105 polymorphism of GSTP1 (glutathione S-transferase) in mothers of asthmatics 25 . The maternal influence is believed to have the greatest influence on atopy or asthma establishment. Surprisingly, we observed that three haplotypes (a1, a2, a3), predominantly the a3 haplotype, were associated with the severity of AHR and were significantly more often paternally transmitted. This different quantity of haplotype effects according to parental origin may be due to a distinct imprinting pattern of the alleles. Some genes are able to fully or partially escape epigenetic reprogramming during prenatal development and so they can preserve their special DNA methylation pattern [26] [27] [28] . Moreover, the specific epigenetic pattern can be transmitted to the descendant, and therefore, the epigenetic changes may be transmitted transgenerationally 25, 26 . However, larger studies and meta-analyses are required to confirm the exact role of ADAM33 SNPs and the role of haplotype in the development of asthma.
